Mai B. Thayer

Statistics

Publications

Citations

313

H-Index

Active since

2019

Affiliations

Amgen (United States)(Current)

Denali Therapeutics (United States)

Ionis Pharmaceuticals (United States)

Mai B. Thayer is an author at Amgen (United States) specializing in rna interference, small interfering ribonucleic acids (sirnas), and small interfering rna biology.

ORCID

Publications per year

2019–2024

Publications

Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · Science Translational Medicine · 2024 · 119 citations

Pharmacy, Neuroscience, Pharmacology +17

Application of Locked Nucleic Acid Oligonucleotides for siRNA Preclinical Bioanalytics

Mai B. Thayer, Julie M. Lade, David R. Doherty et al. · Scientific Reports · 2019 · 44 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +14

Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development

Sara C. Humphreys, Mai B. Thayer, Jabbar Campbell et al. · Journal of Medicinal Chemistry · 2020 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Plasma and Liver Protein Binding of N-Acetylgalactosamine–Conjugated Small Interfering RNA

Sara C. Humphreys, Mai B. Thayer, Julie M. Lade et al. · Drug Metabolism and Disposition · 2019 · 27 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +16

POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices

Mai B. Thayer, Sara C. Humphreys, Kyu Chung et al. · Scientific Reports · 2020 · 24 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +15

1–5 of 8